Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Alcohol Clin Exp Res. 2011 Jun 1;35(11):2030–2038. doi: 10.1111/j.1530-0277.2011.01554.x

Table 1.

Low AW group Higher AW group

PLA FMZ/GBP PLA FMZ/GBP Test for difference

N 18 26 9 7

Age 47.2 ± 11.2 44.1 ± 11.9 50.3 ± 8.5 46.7 ± 5.6 Not significant

Gender N
-Male 14 20 6 6 Not significant
-Female 4 6 3 1 Not significant

Education (years) 14.9 ± 2.6 14.4 ± 2.2 15.0 ± 1.9 13.4 ± 2.5 Not significant

Baseline drinking
-Heavy drinking days, % 91.1 ± 10.0 84.3 ± 16.0 90.2 ± 16.0 86.2 ± 22.0 Not significant
-Days abstinent, % 5.5 ± 5.9 6.4 ± 8.9 9.1 ± 16.0 12.9 ± 22.0 Not significant

Alcohol Dependence Scale
(range: 0–47)
12.4 ± 7.0 12.6 ± 5.8 21.2 ± 10.6 17.6 ± 6.9 Higher AW > Low

Years of alcohol dependence 11.1 ± 8.9 10.3 ± 8.4 16.3 ± 13.6 7.5 ± 8.4 Not significant

Past other substance
dependence N
1 8 2 2 Low AW/FMZ-GBP > Low AW/PLA

POMS Depression subscale
(range: 0–20)
6.3 ± 5.6 5.7 ± 5.0 10.0 ± 6.7 5.3 ± 5.0 Not significant

Demographic and baseline variables, by medication group within alcohol withdrawal (AW) group. All figures except Ns are means ± standard deviations.

FMZ/GBP = flumazenil/gabapentin; PLA = placebos; POMS = Profile of Mood States.